Ознакомительная версия. Доступно 23 страниц из 112
13, 2017): e36.
412
Antonio Paoli et al., “Nutrition and Acne: Therapeutic Potential of Ketogenic Diets,” Skin Pharmacology and Physiology 25, no. 3 (2012): 111-17.
413
Daniela D. Weber, Sepideh Aminzadeh-Gohari, and Barbara Kofler, “Ketogenic Diet in Cancer Therapy,” Aging 10, no. 2 (February 11, 2018): 164-65.
414
Javad Anjom-Shoae et al., “The Association between Dietary Intake of Magnesium and Psychiatric Disorders among Iranian Adults: A Cross-Sectional Study,” British Journal of Nutrition 120, no. 6 (September 2018): 693–702.
415
Alan W. Yuen and Josemir Sander, “Can Magnesium Supplementation Reduce Seizures in People with Epilepsy? A Hypothesis,” Epilepsy Research 100, nos. 1–2 (June 2012): 152-56.
416
Etienne Pouteau et al., “Superiority of Magnesium and Vitamin B6 over Magnesium Alone on Severe Stress in Healthy Adults with Low Magnesemia: A Randomized, SingleBlind Clinical Trial,” PLOS One 13, no. 12 (December 18, 2018): e0208454.
417
Anna E. Kirkland, Gabrielle L. Sarlo, and Kathleen F. Holton, “The Role of Magnesium in Neurological Disorders,” Nutrients 10, no. 6 (June 6, 2018): e730. Emily K. Tarleton et al., “Role of Magnesium Supplementation in the Treatment of Depression: A Randomized Clinical Trial,” PLOS One 12, no. 6 (June 27, 2017): e0180067.
418
Evert Boonstra et al., “Neurotransmitters as Food Supplements: The Effects of GABA on Brain and Behavior,” Frontiers in Psychology 6 (2015): 1520.
419
A. M. Abdou et al., “Relaxation and Immunity Enhancement Effects of Gammaaminobutyric Acid (GABA) Administration in Humans,” BioFactors 26, no. 3 (2006): 201-8.
420
Daniel G. Amen, Memory Rescue (Carol Stream, IL: Tyndale, 2017), 185-86.
421
Там же.
422
“HIV/AIDS and Mental Health,” National Institute of Mental Health, last revised November 2016, https://www.nimh.nih.gov/health/topics/hiv-aids/index.shtml.
423
Nian-Sheng Tzeng et al., “Increased Risk of Psychiatric Disorders in Allergic Diseases: A Nationwide, Population-Based, Cohort Study,” Frontiers in Psychiatry 9 (April 24, 2018): 133.
424
Yi-Hao Peng et al., “Adult Asthma Increases Dementia Risk: A Nationwide Cohort Study,” Journal of Epidemiology and Community Health 69, no. 2 (February 2015): 123-28. Minna Rusanen et al., “Chronic Obstructive Pulmonary Disease and Asthma and the Risk of Mild Cognitive Impairment and Dementia: A Population Based CAIDE Study,” Current Alzheimer Research 10, no. 5 (June 2013): 549-55.
425
Ora Nakash et al., “Comorbidity of Common Mental Disorders with Cancer and Their Treatment Gap: Findings from the World Mental Health Surveys,” Psycho-Oncology 23, no. 1 (January 2014): 40–51.
426
William F. Pirl, “Evidence Report on the Occurrence, Assessment, and Treatment of Depression in Cancer Patients,” JNCI Monographs 2004, no. 32 (July 2004): 32–39.
427
“Women & Autoimmunity,” American Autoimmune Related Diseases Association, accessed August 15, 2019, https://www.aarda.org/who-we-help/patients/women-and-autoimmunity/.
428
Marc Malkin, “Lady Gaga Opens Up about Her ‘Mental Health Crisis,’” Variety, November 9, 2018, https://variety.com/2018/scene/news/lady-gaga-mental-health-struggles-1203023093/.
429
Michael E. Benros et al., “Autoimmune Diseases and Severe Infections as Risk Factors for Mood Disorders: A Nationwide Study,” JAMA Psychiatry 70, no. 8 (August 2013): 812-20. Gianluca Bagnato et al., “Comparation of Levels of Anxiety and Depression in Patients with Autoimmune and Chronic-Degenerative Rheumatic: Preliminary Data,” Reumatismo (Italian) 58, no. 3 (July – September 2006): 206-11.
430
William W. Eaton et al., “Association of Schizophrenia and Autoimmune Diseases: Linkage of Danish National Registers,” American Journal of Psychiatry 163, no. 3 (March 2006): 521-28.
431
Joshua D. Rosenblat and Roger S. McIntyre, “Bipolar Disorder and Immune Dysfunction: Epidemiological Findings, Proposed Pathophysiology and Clinical Implications,” Brain Sciences 7, no. 11 (October 30, 2017): e144.
432
Philip Rising Nielsen, Michael Eriksen Benros, and Søren Dalsgaard, “Associations between Autoimmune Diseases and Attention-Deficit/Hyperactivity Disorder: A Nationwide Study,” Journal of the American Academy of Child and Adolescent Psychiatry 56, no. 3 (March 2017): 234-40.e1.
433
Clare J. Wotton and Michael J. Goldacre, “Associations between Specific Autoimmune Diseases and Subsequent Dementia: Retrospective Record-Linkage Cohort Study, UK,” Journal of Epidemiology and Community Health 71, no. 6 (June 2017): 576-83.
434
Amen, Memory Rescue, 188.
435
Ole Köhler-Forsberg et al., “A Nationwide Study in Denmark of the Association between Treated Infections and the Subsequent Risk of Treated Mental Disorders in Children and Adolescents,” JAMA Psychiatry 76, no. 3 (March 2019): 271-79.
436
Michael E. Benros et al., “Autoimmune Diseases and Severe Infections as Risk Factors for Mood Disorders: A Nationwide Study,” JAMA Psychiatry 70, no. 8 (August 2013): 812-20.
437
Amen, Memory Rescue, 189.
438
R. A. Underhill, “Myalgic Encephalomyelitis, Chronic Fatigue Syndrome: An Infectious Disease,” Medical Hypotheses 85, no. 6 (December 2015): 765-73.
439
Z. Marinković and S. Dukić, “Historical and Medical Review of Syphilis-Afflicted Army Leaders, Rulers and Statesmen,” Medicinski Pregled 64, nos. 7–8 (July/August 2011): 423-27.
440
Lucas Lonardoni Crozatti et al., “Atypical Behavioral and Psychiatric Symptoms: Neurosyphilis Should Always Be Considered,” Autopsy Case Reports 5, no. 3 (July-September 2015): 43–47.
441
Ruth F. Itzhaki et al., “Microbes and Alzheimer’s Disease,” Journal of Alzheimer’s Disease 51, no. 4 (2016): 979-84.
442
James S. Brown Jr., “Geographic Correlation of Schizophrenia to Ticks and Tick-Borne Encephalitis,” Schizophrenia Bulletin 20, no. 4 (1994): 755-75; использовано с разрешения.
Ознакомительная версия. Доступно 23 страниц из 112
